Cargando…

VMAT testing for an Elekta accelerator

Volumetric‐modulated arc therapy (VMAT) has been shown to be able to deliver plans equivalent to intensity‐modulated radiation therapy (IMRT) in a fraction of the treatment time. This improvement is important for patient immobilization/ localization compliance due to comfort and treatment duration,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaurin, Darryl G.L., Sweeney, Larry E., Marshall, Edward I., Mahendra, Saikanth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716421/
https://www.ncbi.nlm.nih.gov/pubmed/22402389
http://dx.doi.org/10.1120/jacmp.v13i2.3725
_version_ 1783283949760413696
author Kaurin, Darryl G.L.
Sweeney, Larry E.
Marshall, Edward I.
Mahendra, Saikanth
author_facet Kaurin, Darryl G.L.
Sweeney, Larry E.
Marshall, Edward I.
Mahendra, Saikanth
author_sort Kaurin, Darryl G.L.
collection PubMed
description Volumetric‐modulated arc therapy (VMAT) has been shown to be able to deliver plans equivalent to intensity‐modulated radiation therapy (IMRT) in a fraction of the treatment time. This improvement is important for patient immobilization/ localization compliance due to comfort and treatment duration, as well as patient throughput. Previous authors have suggested commissioning methods for this modality. Here, we extend the methods reported for the Varian RapidArc system (which tested individual system components) to the Elekta linear accelerator, using custom files built using the Elekta iComCAT software. We also extend the method reported for VMAT commissioning of the Elekta accelerator by verifying maximum values of parameters (gantry speed, multileaf collimator (MLC) speed, and backup jaw speed), investigating: 1) beam profiles as a function of dose rate during an arc, 2) over/under dosing due to MLC reversals, and 3) over/under dosing at changing dose rate junctions. Equations for construction of the iComCAT files are given. Results indicate that the beam profile for lower dose rates varies less than 3% from that of the maximum dose rate, with no difference during an arc. The gantry, MLC, and backup jaw maximum speed are internally consistent. The monitor unit chamber is stable over the MUs and gantry movement conditions expected. MLC movement and position during VMAT delivery are within IMRT tolerances. Dose rate, gantry speed, and MLC speed are accurately controlled. Over/under dosing at junctions of MLC reversals or dose rate changes are within clinical acceptability. PACS numbers: 87.55.de, 87.55.Qr, 87.56.bd
format Online
Article
Text
id pubmed-5716421
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57164212018-04-02 VMAT testing for an Elekta accelerator Kaurin, Darryl G.L. Sweeney, Larry E. Marshall, Edward I. Mahendra, Saikanth J Appl Clin Med Phys Radiation Oncology Physics Volumetric‐modulated arc therapy (VMAT) has been shown to be able to deliver plans equivalent to intensity‐modulated radiation therapy (IMRT) in a fraction of the treatment time. This improvement is important for patient immobilization/ localization compliance due to comfort and treatment duration, as well as patient throughput. Previous authors have suggested commissioning methods for this modality. Here, we extend the methods reported for the Varian RapidArc system (which tested individual system components) to the Elekta linear accelerator, using custom files built using the Elekta iComCAT software. We also extend the method reported for VMAT commissioning of the Elekta accelerator by verifying maximum values of parameters (gantry speed, multileaf collimator (MLC) speed, and backup jaw speed), investigating: 1) beam profiles as a function of dose rate during an arc, 2) over/under dosing due to MLC reversals, and 3) over/under dosing at changing dose rate junctions. Equations for construction of the iComCAT files are given. Results indicate that the beam profile for lower dose rates varies less than 3% from that of the maximum dose rate, with no difference during an arc. The gantry, MLC, and backup jaw maximum speed are internally consistent. The monitor unit chamber is stable over the MUs and gantry movement conditions expected. MLC movement and position during VMAT delivery are within IMRT tolerances. Dose rate, gantry speed, and MLC speed are accurately controlled. Over/under dosing at junctions of MLC reversals or dose rate changes are within clinical acceptability. PACS numbers: 87.55.de, 87.55.Qr, 87.56.bd John Wiley and Sons Inc. 2012-03-08 /pmc/articles/PMC5716421/ /pubmed/22402389 http://dx.doi.org/10.1120/jacmp.v13i2.3725 Text en © 2012 The Authors. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Kaurin, Darryl G.L.
Sweeney, Larry E.
Marshall, Edward I.
Mahendra, Saikanth
VMAT testing for an Elekta accelerator
title VMAT testing for an Elekta accelerator
title_full VMAT testing for an Elekta accelerator
title_fullStr VMAT testing for an Elekta accelerator
title_full_unstemmed VMAT testing for an Elekta accelerator
title_short VMAT testing for an Elekta accelerator
title_sort vmat testing for an elekta accelerator
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716421/
https://www.ncbi.nlm.nih.gov/pubmed/22402389
http://dx.doi.org/10.1120/jacmp.v13i2.3725
work_keys_str_mv AT kaurindarrylgl vmattestingforanelektaaccelerator
AT sweeneylarrye vmattestingforanelektaaccelerator
AT marshalledwardi vmattestingforanelektaaccelerator
AT mahendrasaikanth vmattestingforanelektaaccelerator